Boeri miRNA signature of diagnosis of lung cancer
miRNA expression analyses in plasma samples collected 1ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å"2 y before the onset of disease, at the time of CT detection and in disease-free smokers enrolled in the screening trial, resulted in the generation of miRNA signatures with strong predictive, diagnostic, and prognostic potential (area under the ROC curve ÃƒÂ¢Ã¢â‚¬Â°Ã‚Â¥ 0.85). The signature of diagnosis of lung cancer is comprised of 16 ratios composed from 13 miRNAs: 21, 92a, 140-3p, 17, 106a, 140-5p, 660, 19b, 451, 30c, 15b, 28-3p, 486-5p.
No member markers defined for this panel.
There are no datasets associated with this biomarker.